Methods For Treating Hepcidin-Mediated Disorders
Patent No. EP3329018 (titled "Methods For Treating Hepcidin-Mediated Disorders") was filed by Astrazeneca Pharmaceuticals on Jul 28, 2016. The application was issued on Mar 31, 2021.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3329018
- Application Number
- EP16833574A
- Filing Date
- Jul 28, 2016
- Status
- Revoked
- Nov 23, 2024
- Publication Date
- Mar 31, 2021
- External Links
- Slate, Register , Google Patents